Results 21 to 30 of about 19,206,393 (242)

Modeling the Restricted Mean Survival Time Using Pseudo-Value Random Forests. [PDF]

Stat Med
The restricted mean survival time (RMST) has become a popular measure to summarize event times in longitudinal studies. Defined as the area under the survival function up to a time horizon τ>0$$ \tau >0 $$ , the RMST can be interpreted as the life ...
Schenk A, Basten V, Schmid M.
europepmc   +3 more sources

Omnibus test for restricted mean survival time based on influence function. [PDF]

Stat Methods Med Res, 2023
The restricted mean survival time (RMST), which evaluates the expected survival time up to a pre-specified time point τ , has been widely used to summarize the survival distribution due to its robustness and straightforward interpretation. In comparative
Gu J, Fan Y, Yin G.
europepmc   +2 more sources

Utility of Restricted Mean Survival Time Analysis for Renal Replacement Therapy in Patients with Sepsis Associated Acute Kidney Injury: A Retrospective Study [PDF]

International Journal of General Medicine
Rong Luo,1,* Wei Wang,2,* Jinquan Xia,3 Chuanchuan Nan,4 Silin Liang,4 Jiajia Huang,4 Chengying Hong,4 Chunbo Chen,4 Huaisheng Chen41The Second Clinical Medical College of Jinan University, Department of Critical Care Medicine, Shenzhen ...
Luo R, Wang W, Xia J, Nan C, Liang S, Huang J, Hong C, Chen C, Chen H   +8 more
doaj   +2 more sources

Impact of pulmonary complications following esophagectomy on long-term survival: multivariate meta-analysis and restricted mean survival time assessment. [PDF]

Updates Surg
Pulmonary complications (PC) are common after esophagectomy and their impact on long-term survival is not defined yet. The present study aimed to assess the effect of postoperative PCs on long-term survival after esophagectomy for cancer.
Manara M, Bona D, Bonavina L, Aiolfi A, OGSA Group for Esophagogastric Surgery.   +4 more
europepmc   +2 more sources

GTsurvival: A Hybrid GCN-Neural Decision Tree Model for Restricted Mean Survival Time Prediction with Complex Censored Data [PDF]

Entropy
Chronic diseases, particularly those with progressive neurological impairment, present a significant challenge in healthcare due to their impact on millions globally and the limited availability of effective therapies.
Jingyi Zhang, Shishun Zhao, Dongmei Lu, Jianhua Cheng   +3 more
doaj   +2 more sources

Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival time. [PDF]

Br J Cancer
Metastasis-directed therapy (MDT) with stereotactic body radiotherapy (SBRT) is emerging as an effective therapeutic option for oligometastatic disease (OMD).
Averbuch I, Moore A, Ludmir EB, Markel G, Meirson T.   +4 more
europepmc   +2 more sources

Coronary artery bypass surgery improves restricted mean survival time in patients with ischemic cardiomyopathy [PDF]

American Heart Journal Plus
Introduction: Clinical trials commonly use Cox proportional hazards models, which may be inaccurate when evaluating procedural interventions. Restricted mean survival time (RMST) is an alternative outcome measure that quantifies treatment effects without
Samuel W. Reinhardt, Haocheng Huang, Helen Parise, Tariq Ahmad, Eric J. Velazquez, Kamil F. Faridi   +5 more
doaj   +2 more sources

Scaling and interpreting treatment effects in clinical trials using restricted mean survival time. [PDF]

Clin Trials
Background: Restricted mean survival time is the expected duration of survival up to a chosen time of restriction τ . For comparison studies, the difference in restricted mean survival times between two groups provides a summary measure of the treatment ...
Karrison T, Hu C, Dignam J.
europepmc   +2 more sources

The restricted mean survival time as a replacement for the hazard ratio and the number needed to treat in long‐term studies [PDF]

ESC Heart Failure, 2021
Aims We applied the restricted mean survival time (RMST) to analyse the survival data reported in the PARADIGM‐HT trial in which sacubitril + valsartan was studied in comparison with enalapril in patients with heart failure.
Andrea Messori, Laura Bartoli, Sabrina Trippoli   +2 more
doaj   +2 more sources

Evaluation of Overall Survival by Restricted Mean Survival Time of Advanced Biliary Tract Cancer treated with Immunotherapy: A Systematic Review and Meta-Analysis. [PDF]

Cancers (Basel)
Simple Summary This study addresses the challenge of interpreting the efficacy of immunotherapy in biliary tract cancer (BTC) in terms of overall survival (OS).
Mauro E, Sanduzzi-Zamparelli M, Sauri T, Soler A, Iserte G, Fortuny M, Forner A.   +6 more
europepmc   +2 more sources